Conventional models of one-drug-one-disease are changing fast. Genetic technologies are at the forefront, fueling new discoveries that link diseases, therapies, and patient responses. Thermo Fisher genetic analysis solutions are helping to rapidly drive connections for multi-therapeutic approaches to treat complex human diseases. Wherever you are in your journey from discovery to manufacturing, gain access to a breadth of genetic technologies that enables to you to keep up with the development pace of therapeutics, interventions, and vaccines.
The future of gene therapy
Now more than ever, we need to look to the future of gene therapy. Hear from global CDMO Viralgen as they discuss new product innovations, their partnership with Thermo Fisher Scientific, and challenges faced in gene therapy manufacturing. Viralgen currently uses qPCR reagents in cell and gene therapy (CGT) manufacturing quality control.
E-book: Genetic insights in biopharmaceutical development
Download to learn:
- How genetic analysis is enabling more rapid and efficient clinical trials
- How integration of genetic analysis technologies is evolving in the pharma and biotech spaces
- How companies around the world are deploying genetic analysis to gain competitive advantage
Monoclonal antibody development
Efficiently develop and characterize recombinant monoclonal antibodies (mAbs) from discovery through clinical trials and manufacturing by incorporating genetic-level analysis into your workflows.